Trx enhances anthracycline-mediated apoptosis in breast cancer MCF-7 cells, and, again, TrxR predicts better distant metastasis-free survival in clinical breast cancer material [28, 29], although the prognostic role of Trx has been less clear. Here, TXN is linked to breast carcinoma.